5-Fluorouracil/Leucovorin is named as a drug or biological intervention in 3 clinical trials in our China trial register, 3 of which are recruiting. Lead sponsors include First Affiliated Hospital of Zhejiang University (1), Akeso (1) and Zhai Wenlong (1). Registered phases: Phase 2 and Phase 4. Conditions studied include Bile Duct Carcinoma; Gall Bladder Cancer; Biliary Tract Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07790445 | A Prospective, Open-Label, Randomized Controlled Clinical Study Comparing Hepatic Arterial Infusion Chemotherapy (HAIC) With Capecitabine as Adjuvant Therapy After Radical Surgery for Malignant Biliary Tract Tumors (ClinicalTrials.gov ↗) Malignant Biliary Tract Tumors |
Phase 4 | Recruiting |
| NCT05859750 | A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer (ClinicalTrials.gov ↗) Pancreatic Cancer |
Phase 2 | Recruiting |
| NCT07025174 | Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer (ClinicalTrials.gov ↗) Bile Duct Carcinoma, Gall Bladder Cancer, Biliary Tract Cancer |
Phase 2 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Bile Duct Carcinoma | 1 |
| Gall Bladder Cancer | 1 |
| Biliary Tract Cancer | 1 |
| Cholangiocarcinoma | 1 |
| Pancreatic Cancer | 1 |
| Malignant Biliary Tract Tumors | 1 |
| Lead sponsor | Trials |
|---|---|
| First Affiliated Hospital of Zhejiang University | 1 |
| Akeso | 1 |
| Zhai Wenlong | 1 |
| Register | 5-Fluorouracil/Leucovorin trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how 5-Fluorouracil/Leucovorin works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists 5-Fluorouracil/Leucovorin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.